Dr. Fatima Estrada, MD

Claim this profile
Studies Vaginal Laceration
Studies Administration Site Laceration
1 reported clinical trial
1 drug studied

Clinical Trials Fatima Estrada, MD is currently running

Image of trial facility.

Local Anesthesia

for Vaginal Lacerations

The prevalence of perineal lacerations is more than 75% of all vaginal deliveries. The repair of such lacerations in the institution is usually done using lidocaine for non-epiduralized patients versus no local injection in patients with a pre-existing epidural analgesia. The prevalence of epidural analgesia use among women who underwent vaginal delivery in cross-sectional study of over 2 million deliveries in the United States was 71.1%. Once the analgesic effect of the epidural analgesia fades, the laceration may cause uncontrolled postpartum pain which can affect both the physical and mental recovery period, extend hospital stays, and increase the potential for serious adverse reactions with pain medications. The research hypothesis of this study is that adding a locally injected analgesic, which will take effect once the epidural analgesia fades, may alleviate perineal pain and improve women's overall well-being and satisfaction. This is a superiority two-arm, quadruple-blinded, prospective randomized controlled trial with the objective to determine if prolonged analgesia and higher rate of maternal satisfaction are found when bupivacaine with epinephrine infiltration is used for perineal repair as compared to sham injection in patients with pre-existing effective epidural analgesia at time of perineal laceration repair. Women with a working epidural analgesia, and status post a vaginal delivery involving a second-degree laceration will be invited to participate. Women in the local anesthesia (LA) arm will get a LA injected to the laceration and women in the sham arm will get an injection with saline. The differences in perineal pain between the groups will be evaluated at time of the first analgesic (TFA) demand, maternal satisfaction at 24 hours, and visual analog scale (VAS) pain score.
Recruiting2 awards Phase 43 criteria

More about Fatima Estrada, MD

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Fatima Estrada, MD has experience with
  • Bupivacaine With Epinephrine
Breakdown of trials Fatima Estrada, MD has run
Administration Site Laceration

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Fatima Estrada, MD specialize in?
Fatima Estrada, MD focuses on Vaginal Laceration and Administration Site Laceration. In particular, much of their work with Vaginal Laceration has involved treating patients, or patients who are undergoing treatment.
Is Fatima Estrada, MD currently recruiting for clinical trials?
Yes, Fatima Estrada, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Fatima Estrada, MD has studied deeply?
Yes, Fatima Estrada, MD has studied treatments such as Bupivacaine with Epinephrine.
What is the best way to schedule an appointment with Fatima Estrada, MD?
Apply for one of the trials that Fatima Estrada, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.